Aeterna Zentaris Abstract Accepted for Presentation at

– Company advancing development of its Autoimmunity Modifying AIM Biologicals as a potential therapeutic treatment option for Parkinson’s Disease ("PD"), a...

Related Keywords

Oregon ,United States ,Portland ,Canada ,Toronto ,Ontario ,Oregon Convention Center ,Ukraine ,Canadian ,American ,Jenene Thomas ,Klaus Paulini ,Valentin Bruttel ,Lou Gehrig ,Chi Wang Ip ,Joerg Wischhusen ,C Wang Ip ,S Mamatha Jayaram ,Event Of The American Association Immunologists ,School Of Medicine ,Department Of Neurology ,Company On Twitter ,Linkedin ,Aeterna Zentaris ,Nasdaq ,University Of Wuerzburg The ,Aeterna Zentaris Inc ,American Association Of Immunologists Inc ,Facebook ,Department Of Obstetrics ,European Commission ,American Association Of Immunologists ,University Of Wuerzburg ,Toronto Stock Exchange ,Novo Nordisk ,Autoimmunity Modifying ,Annual Event ,American Association ,Experimental Tumor Immunology ,Therapeutic Approaches ,Based Therapeutics ,Chief Executive Officer ,Litigation Reform Act ,Novo Amended License Agreement ,Annual Report ,Annual Meeting ,Nasdaq Aezs ,Tsezs ,Mmunology2022 ,Im Biologicals ,Diagnostic Products ,Parkinsons Disease ,Iopharmaceutical ,Medicine ,